Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Sleep Number Corporation Q4 2025 Earnings Call - Product Reset Drives Early Sales, But Liquidity Pressure Forces Capital-Structure Fix
Sleep Number delivered the turnaround script they promised, hitting full-year sales of $1.41 billion and adjusted EBITDA of $78 million, while executing roughly $185 million of annualized cost cuts an...
- Full-year net sales were $1.41 billion, in line with prior guidance, and full-year adjusted EBITDA was $78 million, above the $70 million outlook.
- Q4 net sales were $347 million, down 8% year-over-year; fiscal 2025 comparisons were helped by a 53rd week that added roughly 660 basis points to last year’s results.
- Management executed approximately $185 million of annualized cost reductions in 2025 and has identified an additional $50 million of annualized fixed-cost savings to be executed in 2026.
- +11 more takeaways
Full Truck Alliance Q4 2025 Earnings Call - Ecosystem Cleanup and AI Upgrade Shift Growth Toward Quality
Full Truck Alliance closed 2025 with solid profitability and a clear pivot: clean up the platform first, then squeeze more value out of the remaining, higher-quality demand. Orders rose but growth slo...
- Total fulfilled orders were 36.9 million in Q4 2025, up 12.3% year-over-year; full year fulfilled orders reached 236 million, up 19.8% YoY.
- Average monthly active shippers (AMAS) hit 3.28 million in Q4 and 3.14 million for full year 2025, +11.6% and +18.6% YoY, respectively.
- Q4 slowdown in order growth was primarily intentional, driven by a platform-wide ecosystem governance campaign that removed fake accounts, curbed freight reselling and addressed misclassified carpooling orders.
- +12 more takeaways
Montauk Renewables Full Year 2025 Earnings Call - $200M Refinance Funds Turkey NC Launch, But RIN Weakness Squeezes EBITDA
Montauk closed 2025 with mixed operational progress and clear financial tradeoffs. RNG production growth came from expanded capacity at Pico and new processing at Apex, and the company has begun commi...
- Closed new senior credit facility with HASI in March 2026, up to $200 million, $155 million outstanding as of March 11, 2026; fixed interest rate 10.25%, maturity 2031, 24-month availability period and increased total net leverage covenant to 4.0x from 3.0x.
- Turkey, North Carolina project commissioning has started, first-phase capacity to process feedstock from ~400-450k hog spaces (≈35,000 tons annual waste), initial phase capex expected ≈ $200 million, commercial production expected to begin April 2026.
- RNG production showed site-level growth (Pico expansion produced ~31.8% more year-over-year; Apex second facility commissioned), company reported roughly 5.6 million MMBtu of RNG in 2025 (comparable to 2024 on a consolidated basis after asset sale adjustments).
- +11 more takeaways
Gambling.com Group Fourth Quarter 2025 Earnings Call - Data services surge offsets SEO hit
Gambling.com Group reported a record Q4 with revenue of $46.2 million, up 31% year-over-year, and adjusted EBITDA of $15.5 million, up 5% YoY. The call drew a sharp contrast between two businesses: a ...
- Q4 record revenue $46.2m, up 31% year-over-year, adjusted EBITDA $15.5m, up 5% YoY.
- Sports data services (OpticOdds/OddsJam/RotoWire) grew to $11.8m in Q4, up 440% YoY, and accounted for 26% of total revenue, the highest share to date.
- Full-year 2025 revenue $165m, up 30% YoY; full-year adjusted EBITDA up 19%; adjusted free cash flow for 2025 $36.3m.
- +14 more takeaways
Futu Holdings Fourth Quarter and Full Year 2025 Earnings Call - Client growth and margin expansion driven by overseas scale and product push
Futu closed 2025 with aggressive client and revenue momentum. Funded accounts reached about 3.4 million, up 40% year-over-year, after adding roughly 950,000 net new funded accounts in 2025, beating gu...
- Funded accounts reached approximately 3.4 million at year end, up 40% year-over-year after adding more than 950,000 net new funded accounts in 2025, 19% above guidance.
- Management guided to 800,000 net new funded accounts for 2026, the target includes entry into one additional new Asian market.
- Q4 net new funded accounts were ~230,000, down 8% quarter-over-quarter but up 9% year-over-year.
- +15 more takeaways
MariMed Inc. Fiscal Q4 2025 Earnings Call - Brand-led Wholesale Growth Offsets Price Pressure, EBITDA Remains Positive
MariMed closed fiscal 2025 with $159.8 million in revenue, roughly flat with 2024, and reported its sixth consecutive year of positive adjusted EBITDA at $16.9 million (10.5% margin). The story was no...
- Full-year 2025 revenue $159.8 million, roughly +1% vs 2024; Q4 revenue $41.7 million (1.3% sequential growth).
- Non-GAAP EBITDA $16.9 million for 2025, a 10.5% margin, down 12.8% year-over-year; this marks the sixth consecutive year of positive adjusted EBITDA.
- Wholesale revenue grew 11% in 2025 and now represents 44% of total company revenue, up from 40% in 2024. Wholesale is a deliberate growth vector.
- +13 more takeaways
Xunlei Limited Q4 and Fiscal Year 2025 Earnings Call - Pivot to overseas streaming and cloud divestiture fuels top-line surge, GAAP hit from Arashi Vision writedown
Xunlei closed 2025 with a sharp top-line move. Q4 revenue jumped to $143.3 million, up 70% year-over-year, and full-year revenue rose 42.5% to $462.4 million. Management points to subscription resilie...
- Total revenues for Q4 2025 were $143.3 million, a 70% year-over-year increase; full-year 2025 revenue was $462.4 million, up 42.5% versus 2024.
- Subscription revenue remains the stable core: Q4 subscription revenues were $42.1 million, up 22.4% year-over-year; full-year subscription revenue was $154.8 million, up 15.8%.
- Cloud computing staged a strong rebound: Q4 cloud revenue was $46.1 million, up 102.7% year-over-year; full-year cloud revenue was $137.4 million, up 31.4%.
- +12 more takeaways
Harvard Bioscience Q4 2025 Earnings Call - Strategic reset: refinancing, footprint consolidation, and pivot to translational science driving margin recovery
Harvard Bioscience closed 2025 with clear housekeeping done and a new playbook. Q4 revenue of $23.7 million beat the midpoint of guidance, gross margin hit roughly 60%, and adjusted EBITDA jumped 27% ...
- Q4 2025 revenue $23.7 million, slightly above the midpoint of guidance ($22.5M–$24.5M) and down from $24.6M in Q4 2024.
- Q4 gross margin of ~59.8% was at the high end of guidance and the highest in seven quarters, improving ~260 basis points year-over-year.
- Q4 adjusted EBITDA rose 27% year-over-year to $3.8 million; full year adjusted EBITDA increased 12.5% to $8.1 million.
- +12 more takeaways
Aurora Mobile Q4 2025 Earnings Call - First Full-Year GAAP Profit, EngageLab ARR Hits $10M
Aurora Mobile closed 2025 with a clean, unmistakable step up. Q4 revenue jumped to CNY 105.2 million, gross profit hit a 16-quarter high and the company delivered its first ever full-year GAAP net pro...
- Aurora Mobile reported Q4 revenue of CNY 105.2 million, up 13% year-over-year and 16% quarter-over-quarter.
- The company achieved its first full-year GAAP net profit in 2025, and this was the third consecutive profitable quarter.
- EngageLab ARR reached $10 million as of December 2025, a 186% year-over-year increase.
- +16 more takeaways
HERE Group Q2 FY2026 Earnings Call - Makuku-Led 39% Revenue Surge, Offline Push Narrows Margins
HERE reported a sharp quarter of top-line momentum after its shift to a pure-play IP company. Q2 revenue rose to RMB 177.3 million, up 39.4% sequentially, driven largely by flagship IP Makuku (RMB 139...
- Total revenue for Q2 FY2026 was RMB 177.3 million, a 39.4% sequential increase from RMB 127.1 million in Q1.
- Makuku is the dominant revenue driver, contributing RMB 139.4 million or about 73% of Q2 revenue.
- Fenono, launched July 2025, generated RMB 19.2 million in the quarter and is presented as a potential second flagship IP.
- +12 more takeaways